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Introduction
In recent years, miRNAs have been implicated to play a role in regulation of insulin secretion [1] [2] [3] [4] , pancreatic islet development and cell differentiation [5] [6] [7] [8] [9] [10] [11] , insulin resistance [12] [13] [14] [15] , and have been associated with secondary complications of diabetes, such as diabetic nephropathy [16, 17] and cardiovascular disease [18, 19] .
A number of miRNAs have been shown to be directly involved in glucose stimulated insulin secretion (GSIS); indicating potential therapeutic targets for enhancement of GSIS and cell function in Type 2 diabetes.
Mir-375 is, apparently, an important miRNA which negatively regulates GSIS in the murine insulinoma cell line, MIN6, and is thought to act at the late stages of exocytosis through its target myotrophin [1] . Glucose is a negative modulator of mir-375 expression. Mir-375 also negatively regulates insulin gene expression in INS-1E cells by directly targeting PDK1, thereby glucose induced reduction of mir-375 ultimately leads to increased insulin gene expression [20] . Mir-30d expression is also glucose modulated in MIN6 cells and mouse pancreatic islets; with up-regulation of mir-30d levels induced by high glucose concentrations. Over-expression of mir-30d in MIN6 cells leads to increased insulin gene expression, while knockdown leads to reduced expression [21] , although it is unknown whether the effect of glucoseinduced mir-30d on insulin expression is also mediated through PDK1.
Another miRNA mir-124a, targets transcription factor foxa2, which in turn regulates PDX-1 (which regulates insulin transcription) and potassium channel subunits Kir6.2 and sur1. Overexpression of mir-124a leads to increased Ca 2+ levels within MIN6 cells, possibly due to dysregulation of Kir6.2 and sur1 subunits [2] . Overexpression of mir-124a in MIN6 B1 cells led to increased insulin secretion in response to basal ACCEPTED MANUSCRIPT 4 glucose concentrations and reduced secretion in response to stimulatory glucose concentrations [4] . Mir-124a affects the expression of a number of other exocytosis related proteins in MIN6 B1 cells including SNAP25, Rab3A, synapsin-1A, Rab27A and Noc2; although only Rab27A is a direct target of mir-124a [4] . These exocytosisrelated proteins also have predicted binding sites for regulation by other miRNAs, but these still remain to be experimentally validated [22] .
Mir-9 negatively regulates GSIS in INS-1E cells by directly targeting transcription factor onecut2, which in turn regulates granuphilin, a negative modulator of exocytosis [3] . Mir-96 mediated reduction of GSIS in MIN6 B1 cells is also associated with reduced expression of granuphilin and Noc2 exocytosis related proteins.
High levels of mir-34a are observed in islets from diabetic db/db mice. Overexpression of mir-34a in MIN6 B1 cells leads to reduced GSIS, possibly through its target protein VAMP2 which plays a role in -cell exocytosis [23] . Since each miRNA can target multiple mRNAs, regulation of insulin secretion may be controlled by a small network of miRNAs co-ordinately targeting the extensive range of proteins involved in regulation of exocytosis.
This study aimed to identify other potential key miRNAs involved in the network of regulation of insulin secretion, while investigating the feasibility of more globally profiling miRNA expression in glucose responsive compared to glucose nonresponsive MIN6 cells. 
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Materials and Methods
MiRNA target prediction:
The analysis of miRNA-predicted targets was performed using the algorithm miRanda (http://www.microrna.org/microrna/getMirnaForm.do).
Results
Comparison of human versus murine miRNA sequences
No murine TLDAs were available at the time of conducting this study; however, human TLDAs were assessed for suitability to be used in murine experiments.
TLDAs are 384 well cards, including 19 control wells. The 365 remaining wells represent different human miRNAs. The sequence of each was retrieved from the miRNA database -miRBase (www.mirbase.org/) [25] [26] [27] and compared against the murine equivalent sequence to assess homology. 242 of 365 sequences were found to be conserved between human and mouse. For a further 121 sequences there was no murine equivalent registered in miRBase. The remaining 2 miRNA sequences represent what are now described as "dead" miRNAs i.e. sequences which were initially thought to be miRNAs but have more recently been described as potential tRNA fragments.
Novel murine miRNAs
121 of 365 human miRNAs have no murine equivalent registered in miRBase.
However, 21 of these 121 miRNAs were reproducibly detected in all 6 TLDA cards run with the murine MIN6 RNA samples, indicating that these human miRNA sequences may have a conserved murine homolog (Table 1) .
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MiRNA profiling of glucose responsive compared to glucose non-responsive MIN6 cells
The responsiveness of pancreatic cells to glucose is measured as a fold change of insulin secretion in response to glucose stimulation (16.7mM glucose) compared to basal insulin secretion (3.3mM glucose). With increasing time in culture, the GSIS fold change of MIN6 cells decreases [24] .
In order to identify miRNAs which may be responsible for this loss of GSIS, miRNA profiling was performed on glucose responsive MIN6 cells and glucose nonresponsive MIN6 cells using TLDAs. Endogenous controls RNU44, RNU48 and RNU6B were incorporated onto each plate; however none of these transcripts were detected in the samples used. Therefore let-7b was chosen as endogenous control for normalisation, as levels of this miRNA were unchanged in all samples. Following normalisation and application of t-test, differentially expressed targets were identified as miRNAs with P-value < 0.05. Using this criterion 10 differentially expressed miRNAs were identified (Table 2) .
Putative miRNA targets
Microarray and proteomic studies performed in house identified mRNAs [28] and proteins [29] differentially expressed in glucose responsive compared to glucose nonresponsive MIN6 and MIN6 B1 cells. Here, bioinformatic analysis was performed on these mRNA and protein targets using microRNA.org: A resource for predicted microRNA targets and expression, based on the miRanda algorithm (http://www.microrna.org/microrna/home.do) [30, 31] to determine if they could potentially be regulated by the miRNAs identified as of interest in this study. A large number of these mRNAs were found to contain putative binding sites for the target ACCEPTED MANUSCRIPT 9 miRNAs, including several mRNAs of which could potentially be targeted by more than one of the identified miRNAs (Table 3) .
Functional validation of miRNAs
Functional validation of miRNA targets was performed in order to evaluate miRNA effect on GSIS. Pre-mir and anti-mir technology was used to increase and knockdown miRNA levels, respectively. Anti-mir negative, pre-mir negative and untreated controls were performed with each experiment to show that effect on GSIS was due to manipulation of specific miRNA, rather than a more general or random event.
According to our TLDA analysis, each of the 10 miRNAs had reduced expression in glucose non-responsive MIN6 cells (Table 2) ; therefore, pre-mir over-expression of miRNA would be expected to improve GSIS function, while anti-mir reduction of miRNA would be expected to reduce GSIS function.
For miRNAs which exhibited effects on GSIS a large number of experiments were undertaken to determine if these effects were significant as we observed considerable interplate variations in GSIS, and even in basal insulin secretion (3.3mM glucose), the same pre-mir and anti-mir, and the same controls, sometimes stimulated or decreased insulin secretion. Therefore, we can only suggest functional trends rather than an absolutely certain effect. Mir-369-5p, mir-27a, mir-320 and mir-192 also had slight effect on GSIS; however, this effect was not statistically significant. Manipulation of mir-337, mir-532 and mir-379 did not exhibit any functional effects on GSIS.
Discussion
In addition to insulin resistance in muscle, liver and adipose tissues, exhibited by Type 2 diabetes patients, this condition is also often associated with reduced functionality of pancreatic cells. Much is known of the mechanisms of GSIS and the proteins involved therein; however, the specific regulation of exocytosis-related proteins remains less well understood. A small number of miRNAs have been shown to play a role in regulation of components of the insulin secretory pathway [1] [2] [3] . This study aimed to investigate the feasibility of identifying other miRNAs involved in the process of GSIS. In addition to increasing our basic understanding of the relevance of miRNAs in physiological events such as GSIS, miRNAs represent a potential future route of therapeutic targets which could be used to improve cell function in Type 2 diabetes by manipulating expression of components of the exocytosis machinery and may also have relevance with regards to manipulating cells to secrete insulin in a regulated manner for use as cell replacement therapies for Type 1 diabetes.
In order to identify miRNAs involved in GSIS it was necessary to screen all possible miRNAs for differential expression in GSIS capable and incapable cells. TLDAs enable relative quantification of expression of 365 different miRNAs using TaqMan real-time PCR chemistries. These TLDAs were designed for analysis of human miRNA expression; however, the GSIS cell line model to be used in this study (as there is no human GSIS cell lines available for analysis) is of murine origin. In order to overcome this problem, homology comparisons were performed using miRBase to determine the quantity of miRNAs conserved between the two species. 67% of the 365 miRNAs were found to be conserved between human and murine; therefore; due to this high level of conservation, these human TLDAs were deemed suitable for profiling murine miRNA expression.
Of the remaining 33% of the human miRNAs represented, which were thought not to Previous microarray and proteomic studies in our laboratory identified mRNAs [28] and proteins [29] differentially expressed in GSIS compared to non-responsive MIN6
and MIN6 B1 cells. Therefore, the miRanda algorithm was applied here to determine if any of these mRNA and proteins contained potential binding sites for regulation by the miRNAs identified in this study as potentially being involved in regulating GSIS. Little is known of mir-410, and its role in pancreatic cells has not been previously identified, this study suggests it may be involved in the regulation of insulin secretion, although the mechanisms by which mir-410 functions still remain to be deciphered.
Previous studies have reported mir-375, mir-9, mir-124a and mir-96 to play a role in regulation of insulin secretion in rodent pancreatic beta cell lines MIN6, INS-IE and MIN6 B1 cells [1] [2] [3] [4] ; however, in this study, mir-375, mir-9, mir-124a and mir-96
were not differentially expressed between the two populations, indicating that the loss of GSIS in these cells may potentially be via a myotrophin-, granuphilin-and mir124a-independent mechanisms.
While we identified potential functional relevance in GSIS for some of the differentially expressed miRNAs identified in this study, a number of those identified here did not exhibit any functional effect on GSIS when their levels were manipulated in MIN6 cells, these miRNAs may require combined action of more than one miRNA, as miRNAs only tested individually, or these miRNAs may be involved in other changes the cells are undergoing as they lose their GSIS.
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Conclusion
Keeping in mind the limitation that these TLDA cards were designed to detect human miRNAs, 66% of the 365 human miRNA targets have a murine homolog, and therefore human TLDAs are suitable for analysis of murine miRNAs. In addition, by using human TLDAs a further 21 human miRNAs not previously known to exist in mouse have been reproducibly detected in the MIN6 cell line. Mir-410 identified in this study as potentially involved in glucose induced insulin secretion represents a potential therapeutic target for manipulation to maintain/restore GSIS in insulinproducing cells. However, the mechanism by which mir-410 is involved in insulin secretion still remains to be elucidated. 
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